XNCR Q3 2025 Earnings — Xencor, Inc. Revenue & Financial Results | Market Cap Arena

XNCRXencor, Inc.

$890M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$21M+18.0% YoY

Gross Profit

$21M100.0% margin

Operating Income

-$48M-226.3% margin

Net Income

-$6M-28.7% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

-51.8%

Cash Flow

Operating Cash Flow

-$31M

Free Cash Flow

-$31M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$869M

Total Liabilities

$243M

Stockholders' Equity

$625M

Cash & Equivalents

$28M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$21M	$18M	+18.0%
Gross Profit	$21M	$18M	+18.0%
Operating Income	-$48M	-$55M	+13.9%
Net Income	-$6M	-$46M	+87.0%

Revenue Segments

Royalty

$21M100%